Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Feb 8, 2019.

Shortage details

Status
Current
Company
Mylan Institutional, A Viatris Company
Package NDC
67457-422-54
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)
Initial Posting
Feb 8, 2019

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.